Zynerba Pharmaceuticals Inc. (ZYNE) gained 5.67% or 0.52 to $9.69. It is near 146341 shares traded, which is 45.7% compare to the average total volume 320193. The market cap of ZYNE is $131.41 million. The year to date change is -23.76%. The 52 week price range is from $5.42 to $20.0. Price of ZYNE have changed -5.95% during last week. It have changed -18.92% over last month, 0.44% over last 3 months, -26.61% over last 6 months and -47.02% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 10.43. It is 7.64% above current price. The 200-day Moving Averages for ZYNE is 10.57. It is 9.08% above current price. The 52-week High is 20.0. It is 106.40% from the current price. The 52-week Low is 5.42. It is -44.07% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 12.06 on 2018-06-15. Short % to float is 21.60%. There are some statistics of ZYNE. It is has market cap $131.41 million. The share outstanding is 13.56 million. The average volume is 320193. The percent of top 15 Institution holding is 26.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -52.82%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -46.93%.